Author

Sabrina H. van Ierssel

Antwerp University HospitalORCID 0000-0003-2955-4130Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Benson OgunjimiiD· 2 shared Erika VliegheiD· 2 shared Esther BartholomeusiD· 2 shared Koen VercautereniD· 2 shared Kris LaukensiD· 2 shared Pieter MeysmaniD· 2 shared Alexandra VujkoviciD· 1 shared Anna PostovskayaiD· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSystems Biology

Benson OgunjimiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systems BiologybioRxivPreprintNov 29, 2024

Bridging immunotypes and enterotypes using a systems immunology approach

Fabio Affaticati, My Kieu Ha, Thies Gehrmann…·Benson Ogunjimi

The paper links immunotypes and enterotypes through a systems immunology approach, showing they are orthogonal and connected via the blood transcriptome, with associations between specific bacteria and immune health.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky

BioinformaticsFrontiers in ImmunologyPeer-reviewedMay 31, 2023

Leveraging T-cell receptor - epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution

Anna Postovskaya, Alexandra Vujkovic, Tessa de Block…·Pieter Meysman

The paper uses TCR-epitope recognition models to analyze CD8+ T-cell responses in COVID-19 patients, finding that non-critical patients develop unique SARS-CoV-2-specific T-cell responses not seen in critical patients.

5 citations

humanCITE-seq

𝕏 PostBluesky